Enzyme therapy for patients with bone symptoms in the course of hypophosphatasia (HPP for short) has been included in the list of reimbursed drugs effective October 1. Importantly, access to the treatment is available to both children and adult patients with HPP, something both the patients themselves and experts have been calling for.
- Until now, hypophosphatasia has been a disease that has taken away health and life, not to mention dreams. One in three patients, including myself among others, must get around with the help of a wheelchair. Treatment won't fix what the disease has already destroyed, but it can prevent further dramas and open a gateway to a better life for patients," believes Kamila Dratkowicz, president of the Hypogenek Foundation, which works for HPP patients and their f...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
